<!DOCTYPE html>
<html lang="en">

<head>
    <meta charset="UTF-8" />
    <meta name="viewport" content="width=device-width, initial-scale=1.0" />
    <title>Osteoarthritis</title>
    <link rel="preconnect" href="https://fonts.googleapis.com" />
    <link rel="preconnect" href="https://fonts.gstatic.com" crossorigin />
    <link rel="preload" href="https://fonts.googleapis.com/css2?family=Outfit:wght@100..900&display=swap" as="style"
        onload="this.onload=null;this.rel='stylesheet'" />
    <link rel="stylesheet" href="/mkcbiotherapeutics/assets/global.css" />
    <link rel="stylesheet" href="/mkcbiotherapeutics/assets/css/header.css" />
    <link rel="stylesheet" href="/mkcbiotherapeutics/assets/css/contact.css" />
    <link rel="stylesheet" href="/mkcbiotherapeutics/assets/css/footer.css" />
</head>

<body>
    <div id="header"></div>

    <div class="page_banner">
        <div class="page_banner-container container__sidemargin container__maxwidth container__center">
            <div class="page_banner-title">
                <h1>Osteoarthritis of the Knee</h1>
            </div>
            <div class="page_banner-absolute">
                <img src="/mkcbiotherapeutics/assets/images/commonbanner/banner_abs_image.png" />
            </div>
        </div>
    </div>

    <div class="OA_page container__sidemargin container__maxwidth container__center">
        <span class="color2-color font-20">Intra-articular steroids is the ONLY recommended intra-articular
            treatment for KOA </span>
    </div>

    <div class="OA_page container__sidemargin container__maxwidth container__center">
        <span class="color2-color font-20">At least initially, Physicians are likely to use Stempeucel after IA
            steroid failure; Extensive real-world data could broaden use </span>
        <div class="font-18">Physician view of Stempeucel's place in the line of treatment</div>
    </div>

    <div class="OA_page container__sidemargin container__maxwidth container__center">
        <span class="color2-color font-20">Based on US Physician and Payer feedback, 40% of IA steroids/ HA injection
            failure patients will likely use Stempeucel</span>
        <div class="font-18">Based on US Physician and Payer feedback, 40% of IA steroids/ HA injection failure patients
            will likely use Stempeucel</div>
    </div>

    <div class="OA_page container__sidemargin container__maxwidth container__center">
        <span class="color2-color font-20">Summary of Stempeucel Product Clinical Data</span>
        <div class="footer__bottom-container">
            <a class="text_decoration_none color-unset">
                <div class="custom_li text bgcolor-4"></div>
                <span class="color-black font-16 font-weight-500">
                    Stempeucel® Product has shown safety & efficacy in Knee OA & Critical Limb Ischemia (BD & PAD)
                    trials
                </span>
            </a>
        </div>
        <div class="footer__bottom-container bulletins">
            <a class="text_decoration_none color-unset">
                <div class="custom_li bgcolor-5 text"></div>
                <span class="color-black font-14">Significant improvement in overall WOMAC composite index (p &lt;
                    0.0001) with
                    <b>71.43% reduction</b></span>
            </a>
            <a class="text_decoration_none color-unset">
                <div class="custom_li bgcolor-5 text"></div>
                <span class="color-black font-14">
                    Significant improvement in all WOMAC subscores for pain (p &lt; 0.0001) with <b>73.12%
                        reduction</b>,
                    physical
                    function (p &lt; 0.0001) with <b>71.46% reduction</b> and stiffness (p &lt; 0.0001) with
                    <b>77.25%</b>
                    reduction
                </span>
            </a>
            <a class="text_decoration_none color-unset">
                <div class="custom_li bgcolor-5 text"></div>
                <span class="color-black font-14">
                    Significant improvement in VAS score (p &lt; 0.0001) with <b>64.04%</b> reduction compared to
                    placebo
                </span>
            </a>
            <a class="text_decoration_none color-unset">
                <div class="custom_li bgcolor-5 text"></div>
                <span class="color-black font-14">
                    Improvement in pro-inflammatory marker <b>hsCRP</b>, anti-inflammatory marker <b>IL-10 & CTX II</b>
                    (urine)
                </span>
            </a>
            <a class="text_decoration_none color-unset">
                <div class="custom_li bgcolor-5 text"></div>
                <span class="color-black font-14">
                    Cartilage quality is maintained in MFT compartment (most commonly involved based on MRI T2 imaging
                </span>
            </a>
            <a class="text_decoration_none color-unset">
                <div class="custom_li bgcolor-5 text"></div>
                <span class="color-black font-14">
                    Less number of TKR in Stempeucel arm (1 vs. 4 in placebo) at two years follow up
                </span>
            </a>
        </div>
        <div class="footer__bottom-container">
            <a class="text_decoration_none color-unset">
                <div class="custom_li text bgcolor-4"></div>
                <span class="color-black font-16 font-weight-500">
                    In Critical Limb Ischemia (CLI) due to Buerger's Disease and Atherosclerotic PAD:
                </span>
            </a>
        </div>
        <div class="footer__bottom-container bulletins">
            <a class="text_decoration_none color-unset">
                <div class="custom_li bgcolor-5 text"></div>
                <span class="color-black font-14">Shows significant improvement in primary end points (relief of rest
                    pain & ulcer healing)</span>
            </a>
            <a class="text_decoration_none color-unset">
                <div class="custom_li bgcolor-5 text"></div>
                <span class="color-black font-14">
                    Improved vascularity- seen as development of new collaterals in MRA at six months follow up
                </span>
            </a>
        </div>
    </div>

    <div class="OA_page OA_page-gradient_container container__sidemargin container__maxwidth container__center">
        <div class="OA_page_gradient-subcontainer">
            <div class="OA_page_gradient-text color-white">
                <p class="line_height-24">Stempeucel® is approved by CDSCO (Indian FDA equivalent) for treatment of
                    <br>(1) Grade 2 & 3 Osteoarthritis
                    of the knee in non-obese patients with BMI 30Kg m²
                    <br>(2) No-option CLI due to Bruegers Disease &
                    Artherosclerotic Peripheral Arterial Disease
                </p>
            </div>
            <div class="tabbtn">
                <a href="" class="primary-btn text_decoration_none">
                    <span>Learn More</span>
                    <svg xmlns="http://www.w3.org/2000/svg" width="17" height="17" viewBox="0 0 17 17" fill="none">
                        <g clip-path="url(#clip0_590_295)">
                            <path d="M0.967773 1.92676L15.678 16.0241" stroke="#FD7401" />
                            <path d="M0.967489 16.0241L15.6777 16.024L15.6777 1.92676" stroke="#FD7401" />
                        </g>
                        <defs>
                            <clipPath id="clip0_590_295">
                                <rect width="17" height="17" fill="white" />
                            </clipPath>
                        </defs>
                    </svg>
                </a>
            </div>
        </div>
    </div>

    <div id="footer"></div>

    <script src="/mkcbiotherapeutics/assets/global.js"></script>
</body>

</html>